NIOX Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual…more
NIOX Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual…more
Latest RNS from NIOX Group Plc
- holdingsHolding(s) in Company
- tvrTotal Voting Rights
- director_pdmrDirector/PDMR Shareholding & RPT Update
- delistingBlock Listing Cancellation and Interim Review
- interim_resultsInterim Results
Analyst consensus: Buy
As of 10 Nov 2026, 5 analysts rate NIOX Group Plc a Buy, with 100% buy ratings and a mean price target of 82p (range 77p–86p), +29% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 43p against a current price of 65p (-34%), based on EV/EBITDA.